Ubiquigent specializes in the design, development, and supply of drug discovery services, research tools, and technologies focused on the ubiquitin-proteasome system. Their expertise supports the discovery of novel therapeutics targeting protein degradation pathways.
The DUBprofiler-Cell™ assay utilizes activity-based probes to capture active DUBs (i.e. DUBs with reactive catalytic site cysteine residues) within a cell-line or tissue